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for the established clinical risk factors, dilation of the LAD, current smoking
and angina class.
Multiple linear regression analysis showed that luminal renarrowing could
be predicted reliably (R2 = 0.65; P < 0.0001) in this patients group on the
basis of the vessel dilated and only two biological risk factors that reflect
the activation status of blood phagocytes, i.e., the expression of C066 by
granulocytes and the production of IL-l,B by stimulated monocytes.
Conclusions. The results of the present study indicate that activated blood
granulocytes prevent luminal renarrowing after PTCA. while activated blood
monocytes promote restenosis. To validate this new finding further study in
an independent patients group is required.
Cardiac Allograft Vasculopathy
output (CO) were serially measured. In Group II, III and IV, all hearts were pre-
served with CCMP technique in hypothermia for 24 hours. Initial perfusion
pressure of CCMP was set to 5 mmHg with constant flow and the pressure
was monitored during the preservation. After all experimental protocol, tis-
sue water content (tWC) was measured. And ultrastructural findings of my-
ocardium and endothelial cells were evaluated. Recovery rate (post/pre;%)
of cardiac functions. CCM P pressure after 24 hours and tWC were as fol-
lows. In Group IV, ultrastructural findings showed minimal myocardial and
endothelial injury among preservation groups.
% sAP %AF %CF %CO CCMPpress. %tWC
Group I 99.7 ± 0.5 99.7 ± 0.5 99.7± 0.5 99.7± 0.5 (-) 82.2:1: 0.3
Group II 78.0 ± 8.2 52.8 ± 26.5 62.6:1:17.7 56.0±212 11.3:1:2.2 66.3±21.2·
Group III 87.1 ± 6.8 83.5± 10.7t 82.3± 12.0t 82.8± 8.9 t 8.2±1.3t 83.2:1: 2.9
Group IV 91.5 ± 4.2 89.2 ± 9.21 96.5±11.71 91.5± 5.41 5.2:1:0.21 84.7:1: 17
% Change in Vascular Wall Cell Proliferation
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This inhibitory effect of estradiol treatment on the mitogenic effect of IGF-I
and IL-6 on the vascular wall of the allograft supports previous studies show-
ing that accelerated coronary transplant arteriosclerosis in this model is in-
hibited by estrogen. These data speak to the use of hormone replacement
therapy in post menopausal women receiving a cardiac transplant.
Intrathymic Injection of Donor Splenocytes
Prolongs Rat Cardiac Allograft Survival but Does
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GROUPS Inflammation % Vessels % Luminal Intima:Media
Diseased Occlusion Ratio
Control (A) severe 89 ± 1 64± 5 0.97 ± 0.33
Splenocyte only (e) moderate-severe 79 ± 8 57 ± 7 068:1: 0.16
ALS only (B) minimal 25 ± 7*' 8± 3·· 0.09 ± 0.04'
Splenocyte + ALS (D) minimal 27 ±4" 8 ± 3" 0.07:1: 0.03'
Chronic rejection, manifested by the development of graft arteriosclerosis.
remains the leading cause of late death in cardiac transplant recipients. Im-
munologic mechanisms have been implicated in both experimental and clini-
cal studies. yet the pathogenesis of chronic allograft rejection remains poorly
understood. Recent studies have shown that intrathymic (i.t.) injection of
donor cells or processed allo-MHC antigens with or without transient im-
munosuppression induces specific systemic T cell tolerance and prevents
acute allograft rejection in several experimental transplantation models. In
this study we examined the effects of i.t. injection of donor cells with or with-
out systemic anti-lymphocyte serum (ALS) on the development of chronic
rejection in the Lewis-to-F344 rat cardiac allograft model. Recipients were
divided into 4 groups: control group A was pre-treated with saline i.t., group
B was pre-treated with a one-time dose of ALS (1 mil via intraperitoneal in-
jection (i.p.). group C received donor (Lewis) splenocytes i.t. (2 x 106), and
group D received both the splenocytes i.t. and a one-time dose of ALS i.p.
two weeks prior to transplantation. Allografts were followed by daily palpa-
tion and graded from Q-4 (grade 0 = rejection, grade 4 = normal heartbeat).
Graft survival on post-op day 90 for all three experimental groups was 100%
vs. 33% for the control (n = 6/group). Moreover, mean heartbeat grade for
the three experimental groups (B = 2.83 ± 0.17, C = 2.0 ± 0.41. 0 = 2.67
± 0.21) was significantly higher (p < 0.01) than that of the control group (A
= 0.4 ± 0.24). Histologic and immunocytochemical analysis of 90-day old
grafts revealed the following results:
'p < 0.05 Group I vs II, t P< 0.05 Group II vs III. I p < 0.05 Group III vs IV
Conclusions: 1I CCMP with oxygenated UWs improved post-ischemic car-
diac functions and suppressed tissue edema in prolonged heart preser-
vation. 2) Addition of ETA antagonist suppressed damaged endothelium-
dependent vasoconstriction and also showed excellent functional recovery
and minimal myocardial injury.
'p < 0.02. "p < 0.003 vs. Control
1936-851
Chronic Estradiol Treatment of Rabbits with
Cardiac Allografts Attenuates Graft Vascular
Proliferation Induced by Insulin-like Growth
Factor-I (IGF-I) and Interleukin-6 (IL-6)
IGF-I (20 Itg/ml) INF-y (50 U/ml) IL.£ (50 U/ml)
Native
- Estradiol 175 ± 32 189 ± 43 162± 28
+ Estradiol 167 ± 42 143 ± 79 159 ± 36
Allograft
- Estradiol 328 ± 66 197 ± 56 366 ± 101
+ Estradiol 64± 12 116±41 72± 14
Mean ± SEM
Hong Lou, Teruaki Kodama, Nevin Katz, Marie Foegh. Georgetown University
Medical Center, Washington, DC
Male New Zealand White rabbits fed a 0.5% cholesterol diet (n = 13) re-
ceived a heterotopic cardiac allograft and cyclosporine (10 mg/kg/day) until
sacrifice 6 to 7 weeks later, at which time both the native and transplanted
hearts and aorta were harvested. Six of the rabbits were treated with estra-
diol 100 Itglkg/day i.m.. beginning 7 days prior to transplantation and con-
tinuing until sacrifice; the remaining seven rabbits served as controls and
received placebo. The native aorta as well as the aorta from the grafted
hearts were isolated and used for in vitro studies involving cytokine and
growth factor stimulated cell proliferation. Tritiated thymidine incorporation
is expressed as CPM/mg protein and the changes in cell proliferation are
expressed as % changes from the control (the unstimulated vessel). IGF-I
and IL-6 but not interferon-y (INF-y) significantly increased cell proliferation,
measured as 3H-thymidine incorporation. in explants from both native and
allograft vessels and significantly more so in the graft (p < 0.05). The mito-
genic effect of both IGF-I and IL-6 in the graft aorta, but not in that associated
with the native heart, was abrogated by chronic treatment with estradiol (p
< 0.02).
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Prolonged heart preservation by simple cold storage in University of Wis-
consin solution (UWs) and its deteriorative effect on endothelial function
have been problematic. We have studied whether continuous coronary
microperfusion (CCMP) technique with oxygenated UWs improves post-
ischemic functional recovery and addition of endothelin (ET) A receptor
antagonist (FR139317) reduces damaged endothelium-dependent vasocon-
striction. Twenty three isolated hearts of Japanese white rabbits were di-
vided into four groups according to preservation methods or modification of
UWs. Group I (control non-preserved). Group II (with original UWs), Group
III (with oxygenated UWs) and Group IV (with oxygenated UWs contained
10 mgll of FR139317). Cardiac functions of isolated hearts were evaluated
by Langendorf! apparatus. As pre and post-ischemic functional parameters,
systolic aortic pressure (sAP), aortic flow (AF), coronary flow (CF) and cardiac
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1936-841 Efficacy of Endothelin A Receptor Antagonist(FR139317) for Long-term Heart Preservation
Conclusions: (1) The induction of systemic unresponsiveness with donor
splenocyte i.t. plus ALS i.p. or ALS i.p. alone markedly reduced inflamma-
tion and inhibited graft arteriosclerosis indicating that the immune response
and graft inflammation playa critical role in the pathogenesis of chronic al-
lograft rejection. (2) The donor cells 1.1. alone significantly prolonged graft
survival and prevented rejection as measured by functional criteria but did
not significantly inhibit graft inflammation or graft arteriosclerosis. These re-
sults suggest that partial suppression of the immune response without sig-
nificant inhibition of graft inflammation prolongs rat cardiac allograft survival
but does not prevent graft arteriosclerosis.
Plasma Fibrinogen Level Predicts Severity of
Intimal Thickening After Cardiac Transplantation
Clyde R. Meckel. Todd J. Anderson, Gilbert H. Mudge, Peter Ganz. Daniell. Simon.
Brigham and Women's Hospital, Boston. MA
Diffuse atherosclerosis is the primary reason for late graft failure after car-
diac transplantation. Because there is increasing evidence that imbalances
in the hemostatic and fibrinolytic pathways are associated with allogeneic re-
